Biochemistry, Genetics and Molecular Biology
Accuracy
10%
Anidulafungin
23%
Animal
10%
Binding Protein
14%
Candida
16%
Candida Albicans
27%
Candida Glabrata
19%
Candida Parapsilosis
21%
Case Report
16%
Codon
36%
Consensus Sequence
10%
Copy-Number Variation
9%
Development
13%
DNA
12%
Ebolavirus
16%
Echinocandin
32%
Electric Potential
26%
Ergosterol
25%
Evolution
35%
Expression Quantitative Trait Loci
13%
Gain of Function Mutation
9%
Gene Expression
14%
Genetic Code
19%
Genetic Divergence
21%
Human
15%
Human Genome
12%
Infectious Agent
19%
Length
9%
Lysozyme
18%
Messenger RNA
13%
Metabolic Pathway
10%
Microarrays
11%
Missense Mutation
10%
Mutation
71%
Nav1.5
16%
Nested Gene
100%
Next Generation Sequencing
13%
Nicotinamide Adenine Dinucleotide
41%
Nicotinamide Phosphoribosyltransferase
25%
ORFeome
9%
Organisms
17%
Pichia kudriavzevii
11%
Polar Bear
9%
Proteome
30%
Sample
61%
Sequencing
9%
Species
27%
Transcription Factor
24%
Upregulation
11%
Yeast
26%
Immunology and Microbiology
Ambiguity
8%
Biofilm
17%
Blood Product
10%
Candida Albicans
23%
Candida Glabrata
19%
Candida Krusei
11%
Candida Parapsilosis
21%
Cells
11%
Chimpanzee
8%
Codon
32%
Consensus Sequence
10%
Cross-Resistance
15%
Development
11%
DNA Conformation
8%
Ebola Virus
16%
Elbow
16%
Electric Potential
28%
Evolution
17%
Gain of Function Mutation
9%
Gene
56%
Genetic Code
17%
Human
12%
Human Genome
13%
Immunocompromised Patient
8%
Infectious Agent
17%
Macrophage
12%
Major Gene
8%
Malassezia
16%
Metagenomics
13%
Minimum Inhibitory Concentration
22%
Multidrug Resistance Protein 1
8%
Mutant
10%
Mutation
59%
Nicotinamide Phosphoribosyltransferase
32%
Orangutan
8%
Organisms
15%
Pathogenicity
22%
Peritoneal Fluid
10%
Phenotype
11%
Polar Bear
9%
Protein Protein Interaction
10%
Pseudogene
8%
Saliva
13%
Sample
34%
Species
39%
Surface Property
20%
Terbinafine
9%
Tissues
12%
Transcription Factor
28%
Virulence
16%
Medicine and Dentistry
Alzheimer's Disease
16%
Ambiguity
8%
Amino Acid
8%
Anidulafungin
23%
Antifungal Agent
21%
Biological Marker
13%
Blood
14%
Codon
16%
Combination Therapy
18%
Comprehension
8%
Consensus Sequence
10%
Cross Resistance
15%
Development
13%
Diagnosis
23%
Diseases
14%
Enzyme
10%
Evolution
14%
Family
12%
Gene
45%
Gene Expression Profiling
16%
Hospital
9%
Human
12%
In Vitro
26%
Leucine
8%
Malassezia
16%
Malignant Neoplasm
9%
Microarray
11%
Neoplasm
16%
Neurodevelopmental Disorder
16%
Next Generation Sequencing
12%
Nicotinamide Adenine Dinucleotide
10%
Nicotinamide Phosphoribosyltransferase
30%
Nicotinate Phosphoribosyltransferase
32%
Pathogenicity
16%
Patient
19%
Peritoneal Fluid
10%
Phenotype
9%
Phylogeny
8%
Prochloraz
13%
Protein
22%
Protein Binding
9%
Pyrrole
16%
Pyrrole Derivative
13%
Saliva
21%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Species
27%
Terbinafine
9%
Therapeutic Procedure
16%
Tissues
15%
Voriconazole
32%
